IFRS 9 · Healthcare

IFRS 9 ECL Calculator
for Healthcare

Pre-configured for healthcare entities with mixed payer analysis — government/NHS receivables (low risk), insurance company receivables, and patient co-pay receivables (higher risk).

Benchmark rates loaded. These are illustrative only. Replace with entity-specific historical loss data for IFRS 9 compliance.

Provision Matrix

Define aging buckets, enter gross carrying amounts and historical loss rates. Per IFRS 9.B5.5.35.

Forward-Looking Adjustment

Required by IFRS 9.5.5.17. Purely historical rates are not IFRS 9 compliant.

Advanced Features

Optional: probability-weighted scenarios, movement schedule, specific assessment, and entity details.

IFRS 9 ECL Audit Working Paper Template — free PDF

Practical audit guide covering the simplified approach provision matrix methodology, forward-looking adjustment documentation template, probability-weighted scenario framework, IFRS 7.35H movement schedule template, common ISA 540 findings on ECL estimates, and industry benchmark loss rates for 12 sectors.

No spam. Unsubscribe anytime.

IFRS 9 Expected Credit Losses for Healthcare

Healthcare entities face unique IFRS 9 ECL challenges because their receivable portfolio typically consists of multiple payer classes with fundamentally different credit risk profiles. Government and public health system receivables (NHS in the UK, Medicare/Medicaid equivalents in other jurisdictions) are virtually certain to be collected but may involve extended payment delays. Insurance company receivables carry the intermediary credit risk of the insurer plus dispute risk on claim amounts. Patient self-pay and co-pay receivables have the highest default rates, often ranging from 10–30% for amounts over 90 days past due. This mixed payer profile means that a single provision matrix applied to all healthcare receivables will produce a blended rate that may not accurately reflect any individual payer class. Best practice is to segment receivables by payer type and apply separate loss rates to each segment within the provision matrix.

Receivable Characteristics — Healthcare

Government/public payer receivables are characterised by high certainty of collection but slow payment cycles — 60 to 120 days is common for NHS and equivalent systems. Insurance company receivables depend on the insurer's claims processing efficiency and any disputes over treatment eligibility or coding. Patient self-pay receivables are typically small, numerous, and carry the highest credit risk. Grant receivables from research funding bodies (government agencies, charities, EU programmes) carry compliance risk — if the entity fails to meet grant conditions, the receivable may not be collectible. Pharmaceutical rebate receivables and medical supply manufacturer rebates represent another category with dispute risk. For private hospital groups, corporate account receivables from employers providing health insurance benefits add another payer dimension.

Forward-Looking Factors

Forward-looking indicators for healthcare ECL vary significantly by payer type. For government receivables, healthcare budget allocation trends and political risk (budget cuts, payment delays during fiscal stress) are the primary factors. For insurance receivables, the solvency and claims payment behaviour of the insurance counterparties matter most. For patient self-pay receivables, unemployment rates, household income trends, and consumer confidence indices are directly relevant. Industry-specific factors include healthcare regulatory changes that may affect reimbursement rates and the overall demand for healthcare services.

Key forward-looking indicators for healthcare:

  • Government healthcare budget allocations
  • Insurance sector solvency indicators
  • Unemployment rate (patient self-pay ability)
  • Healthcare regulation changes
  • Hospital/clinic occupancy rates

Regulatory and Audit Context

Auditors of healthcare entities should verify that the payer mix segmentation in the provision matrix is appropriate and that loss rates reflect the actual credit experience for each payer class. A common deficiency is applying a single blended loss rate across all payer types, which understates the ECL for self-pay receivables and overstates it for government receivables. For entities receiving government grants, the auditor should evaluate whether the grant receivable is within IFRS 9 scope (financial asset) or represents a government grant under IAS 20 (different impairment treatment). Healthcare entities subject to clinical negligence claims may have receivables from insurers or patients that are disputed — these should be individually assessed.

Healthcare entities receiving public funding should separately disclose ECL for government receivables and private-sector receivables. Clinical negligence receivables (from insurers or patients) that are under dispute should be individually assessed.

Worked Example — MedCare Private Hospital Group

MedCare Private Hospital Group operates 5 hospitals with €2.8M in trade receivables at year-end. The payer mix is: insurance companies 55%, government/NHS 25%, patient self-pay 15%, and corporate accounts 5%. The neutral FL factor reflects stable healthcare market conditions and stable insurer solvency.

Bucket Amount Rate ECL
Not yet due €1.600.000 0.20% €3.200
1–30 days €580.000 0.60% €3.480
31–60 days €310.000 2.00% €6.200
61–90 days €160.000 6.00% €9.600
91–180 days €100.000 14.00% €14.000
180+ days €50.000 38.00% €19.000
Total €2.800.000 €55.480

Forward-looking adjustment factor: 1× applied to all buckets. Rates shown above are adjusted rates (historical × FL factor).

Typical receivable profile: Healthcare receivables span a wide risk spectrum: government/NHS receivables have near-certain collection but slow payment cycles, insurance company receivables carry intermediary credit risk with dispute potential, and patient self-pay/co-pay receivables have significantly higher default rates. Grant receivables from research funding bodies carry condition-compliance risk rather than credit risk.

Frequently Asked Questions — Healthcare

Should healthcare receivables be segmented by payer type in the provision matrix?
Yes, this is strongly recommended. Government/NHS receivables, insurance company receivables, and patient self-pay receivables have fundamentally different credit risk profiles. A single blended provision matrix will understate ECL for high-risk payer classes and overstate it for low-risk classes. Best practice is to either run separate provision matrices per payer type or apply different loss rates within a single matrix based on payer classification.
What ECL rate should be applied to government/NHS receivables?
Government and NHS receivables typically carry near-zero credit risk (government entities rarely default on payment obligations), but they are not exempt from IFRS 9 ECL assessment. A very low rate of 0.01–0.1% is appropriate for the 'not yet due' bucket, reflecting the residual risk of administrative rejection or dispute. Receivables that are significantly overdue relative to normal government payment cycles may warrant higher rates, as persistent non-payment from a government entity may signal a dispute rather than a timing delay.
How should medical grant receivables be treated for IFRS 9 purposes?
The treatment depends on the nature of the grant. If the grant is a financial asset (unconditional right to receive cash), it is within IFRS 9 scope and requires ECL assessment. If the grant is conditional on future performance (e.g., research milestones not yet met), it may be a contingent asset outside IFRS 9 scope until the conditions are met. Government grants under IAS 20 that have been recognised as receivables are within IFRS 9 scope, but the credit risk of a government counterparty is typically very low.
What is a typical overall ECL rate for healthcare trade receivables?
Effective overall ECL rates for healthcare entities typically range from 1% to 3.5% of total gross receivables, but this varies enormously depending on the payer mix. Entities with predominantly government/insurance payers will be at the low end (1–1.5%), while entities with a significant self-pay component may be at 3–5% or higher. These are benchmarks only — entity-specific data is required for IFRS 9 compliance.
How should disputed insurance claims be handled in the ECL calculation?
Disputed insurance claims should be individually assessed if material. The dispute risk is not the same as credit risk — the insurer may be creditworthy but contesting the claim amount. For disputed claims, consider: the nature and stage of the dispute, the entity's historical success rate in resolving disputes, and the expected recovery amount. Disputed amounts should be excluded from the collective provision matrix and assessed specifically, with the ECL reflecting the probability-weighted expected outcome of the dispute.